Webinar Series
NEXT UP: September 11, 2024 at 12-1PM
New Therapeutics for Treatment-Resistant Depression
with James Murrough, MD, PhD
Purpose Statement:
The purpose of this live, knowledge-based virtual presentation for interprofessional healthcare teams will discuss how Major depressive disorder (MDD) is the leading cause of disability worldwide and a major cause of disability and suffering among U.S. Veterans. Depression is a leading contribute to risk for suicide. A significant proportion of individuals with MDD do not show an adequate response to first line treatment for MDD and can be described as suffering from treatment-resistant depression (TRD). This presentation aims to fill the knowledge gap concerning what treatments are currently available for TRD, and what new treatments may be on the horizon.
Outcome/Objectives:
At the conclusion of this educational program, learners will be able to:
1. review and consider current evidence base for treatments for TRD; and
2. provide evidence-based treatments for TRD.
Program Description:
The VISN 2 Mental Illness Research, Education and Clinical Centers (MIRECC) pursues a discovery-to-recovery approach to determine the causes, identify predictors, and develop treatments for individuals with SMI, with emphasis on psychosis and on suicide. The topics for this series consist of innovative treatments that we have created/tested and insights from research that have helped to inform clinical care.
Target Audience (1 CE Per Webinar):
Physicians, Psychologists, Social Workers, Nurses, Counselors, and Therapists
Registration:
VA Providers (TMS #131010812)
Non-VA Providers (TRAIN #1122531)
PRESENTER:
James Murrough, MD, PhD is Associate Professor of Psychiatry and Neuroscience, Director of the Depression and Anxiety Center for Discovery and Treatment, faculty member of the Friedman Brain Institute, and a primary principal investigator of the Center of Excellence in Neuropharmacology, all at the Icahn School of Medicine at Mount Sinai. He conducts clinical and translational research aimed at understanding the biological basis of mood and anxiety disorders in order to point the way towards new, more effective treatments.
Dr. Murrough received his bachelor of science in neuroscience and behavioral biology from Emory University and his medical degree from Tufts University School of Medicine. He completed residency training in psychiatry, a research fellowship in experimental therapeutics and clinical neuroscience, and a PhD in clinical research from Mount Sinai. Dr. Murrough has received research support from the National Institutes of Health, the Doris Duke Charitable Foundation, the American Foundation for Suicide Prevention, the Dana Foundation and the Brain and Behavior Research Foundation. He is a Member of the American College of Neuropsychopharmacology and an active member of the scientific community. In addition to his research and educational activities, Dr. Murrough oversees a clinical program at Mount Sinai focused on evidence-based treatments for treatment-resistant depression and other refractory forms of mood and anxiety disorders.
Accreditations: ACCME, ACCME-NP, APA, ASWB, JA IPCE, NBCC, NYSED SW, NYSED-Psychology
Additional Information for TMS Registration:
Questions?
Non-VA employees, please contact the VHA TRAIN Help Desk by email at VHATRAIN@va.gov.
VA employees, please contact Lauran Hardy at Lauran.Hardy@va.gov.
Last updated: September 3, 2024
